Moderna Company Profile

Aggregated data from the web about Moderna

Company Name	Moderna
Website	https://www.modernatx.com
Snippet	Moderna Therapeutics is pioneering a new class of drugs, messenger RNA Therapeutics, with the vast potential to treat many diseases across a range of drug modalities and therapeutic areas.
ISIN	US60770K1079
Type	Public
Owner	Noubar Afeyan (12.7%)Stéphane Bancel (7.9%)Robert S. Langer (2.9%)Stephen Hoge (1.3%)
Founded	2010
Revenue	US$803 million (2020)
Website	modernatx.com
Formerly	ModeRNA Therapeutics(2010–2018)
Founders	Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
Industry	Biotechnology
Products	Moderna COVID-19 vaccineVaccine candidates
Traded as	Nasdaq: MRNA, Nasdaq-100 component, S&P 500 component
Key people	Stéphane Bancel, CEO, Stephen Hoge, President, David Meline, CFO, Noubar Afeyan, Chairman, Robert S. Langer, Director, Paul Sagan, Director
Net income	US$−747 million (2020)
Headquarters	200 Technology SquareCambridge, Massachusetts, U.S.
Total assets	US$7.336 billion (2020)
Total equity	US$2.561 billion (2020)
Operating income	US$−763 million (2020)
Number of employees	1,800+ (2021)

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.